Literature DB >> 3018411

Amiloride potentiates atrial natriuretic factor inhibitory action by increasing receptor binding in bovine adrenal zona glomerulosa.

A De Léan.   

Abstract

The interaction of atrial natriuretic factor (ANF) with the diuretic amiloride was studied in bovine adrenal zona glomerulosa. Amiloride enhances 2 to 3-fold high affinity binding of [125I] ANF to zona glomerulosa membrane receptor with an ED50 of 10 microM. This effect is due to a recruitement of high affinity receptor sites and to an increase of their affinity from a Kd of 23 to 8 pM. This enhancing effect is almost equipotently elicited by guanabenz, while clonidine is 20-fold less potent and arginine is inactive. ATP reduces by 30 to 50% [125I] ANF binding with an IC50 of 50 microM. Amiloride and ATP opposite effects on [125I] ANF binding are mutually competitive. Low concentrations of amiloride (less than 100 microM) potentiate the inhibitory effect of ANF in hormone-stimulated steroid secretion with a 3-fold decrease in ANF IC50 at 10 microM amiloride. Higher concentrations of amiloride (greater than 100 microM) directly inhibit aldosterone secretion with an IC50 of 500 microM and a maximum of 80 to 100% reversal of stimulation by various secretagogues. These results indicate that amiloride synergistically potentiates ANF inhibitory action by altering ANF receptor binding properties. They also suggest a role for sodium transport and for phosphorylation-dephosphorylation mechanisms in the mode of action of ANF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018411     DOI: 10.1016/0024-3205(86)90203-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Nucleotide regulation of heat-stable enterotoxin receptor binding and of guanylate cyclase activation.

Authors:  L C Katwa; C D Parker; J K Dybing; A A White
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

Review 2.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

Review 3.  Receptor sites for atrial natriuretic factors in brain and associated structures: an overview.

Authors:  R Quirion
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

4.  Purification and properties of active atrial-natriuretic-peptide receptor (type C) from bovine lung.

Authors:  K Uchida; T Mizuno; M Shimonaka; N Sugiura; K Nara; N Ling; H Hagiwara; S Hirose
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

5.  Phosphorylation of the kinase homology domain is essential for activation of the A-type natriuretic peptide receptor.

Authors:  L R Potter; T Hunter
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

6.  The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction system.

Authors:  M B Anand-Srivastava; J Gutkowska; M Cantin
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

7.  Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine protein kinases: evidences for receptor regulation.

Authors:  L Larose; J J Rondeau; H Ong; A De Léan
Journal:  Mol Cell Biochem       Date:  1992-10-07       Impact factor: 3.396

8.  Atrial natriuretic peptide and angiotensin II binding sites in cerebral capillaries of spontaneously hypertensive rats.

Authors:  M Ibaragi; M Niwa
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

9.  Hormonal induction of low affinity receptor guanylyl cyclase.

Authors:  J R Jewett; K J Koller; D V Goeddel; D G Lowe
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.